Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeGeneral Motors Co.Strict Protocols in Place to Protect the Health of the GM Team...

Strict Protocols in Place to Protect the Health of the GM Team Building Ventec’s Critical Care Ventilators in Kokomo

General Motors Co. is actively training employees at the company’s Kokomo plant in the extensive screening, cleaning and other CDC-recommended procedures that will be in place when volume production of Ventec Life Systems’ critical care ventilator begins in less than two weeks. Among the employees is UAW Local 292 member Debbie Hollis of Kokomo. The news was announced today.

Hollis states, “I have family all across the country, so (COVID-19) has impacted everybody that I know and love.” Hollis added, “I’m grateful that I get a chance to do my part and be a part of something…we are modern-day Rosie the Riveters.”

Hollis and the production team, which will grow to more than 1,000 men and women, including people who already work for GM and new hires from the Kokomo area, are also gaining hands-on exposure to Ventec’s ventilator.

“Every ventilator we build can help save lives, and GM’s global supply base and manufacturing teams, the UAW, and the Kokomo community are working with passion and unwavering commitment to getting the job done,” said Gerald Johnson, GM executive vice president, Global Manufacturing. “People have moved mountains to help increase the production of Ventec’s critical care ventilator and we are just weeks away from delivering these lifesaving devices. I have never seen anything like it in my career.”

Kokomo Mayor Tyler Moore said his community is more than ready to do its part, “At this critical moment in our country’s battle against the COVID-19 pandemic, the Kokomo community applauds GM and Ventec leadership for joining the fight by producing much-needed medical ventilators here in their Kokomo facilities. At the same time, they have placed their trust in our community and the incredible Kokomo-area workforce. Kokomo is deeply honored to be a part of this extraordinary endeavor in these extraordinary times.”

Saving Lives and Keeping People Safe
To help protect people working at the Kokomo plant, extensive screening, cleaning, and other CDC-recommended procedures will be in place.

Arrival for Work:

  • Everyone arriving for work will be required to sanitize their hands immediately upon arrival and have their temperature checked with a non-contact thermometer before entering the job site.
  • Everyone will work their shift wearing medical-grade protective masks, including masks produced at GM’s Warren, Michigan facility.

At Work:

  • There will be a 30-minute interval between shifts to allow employees to clean their workstations when they arrive and again before they leave.
  • There will be signage throughout the facility reminding team members to practice social distancing.
  • Each workstation will be manned by one person, and each workstation will be spaced at least six feet apart.
  • Cleaning crews will clean and sanitize common touch surfaces such as door handles, as well as common areas, at least three times per shift.

Between Shifts:

  • Initial production will begin with one shift, with second and third shifts added soon thereafter.
  • Each shift will enter and exit through a different door to minimize social contact.

“The men and women building these ventilators raised their hands to help save the lives of people suffering from COVID-19,” said Dr. Jeffery E. Hess, GM corporate medical director. “We will create a safe workplace using CDC guidelines and scientific data.”

Strong Support from UAW Leadership: The health and safety of every person who enters a GM facility is the top priority for GM and the UAW, especially as people come together to meet the country’s need for ventilators.

“As our nation struggles with the COVID-19 pandemic, volunteer UAW-GM members are doing a tremendous service for our country by volunteering to come to work to make ventilators in Kokomo,” said Terry Dittes, vice president, UAW-GM Department. “For that reason, the UAW has worked with GM to put in place stringent CDC health and safety protocols. Our goal is to make sure that each and every day, people return home to their families and communities safe and healthy. We applaud their courage in volunteering in our nation’s time of need, and we commend GM for working with the UAW to save lives across this country.”

Added Greg Wohlford, UAW Local 292 shop chairperson, “Our members responded to the call for help with courage and a desire to help America save its citizens’ lives. We have pledged, along with GM, to do everything we can to make sure that we keep these everyday heroes safe from illness and injury. The UAW is excited about working with Ventec and GM to produce ventilators in Kokomo, Indiana.”

A Phone Call Sets an Unprecedented Effort into Motion  : The unprecedented teamwork that has allowed ventilator production in Kokomo to move forward so quickly began with a March 17 phone call between General Motors Chairman and CEO Mary Barra and representatives of StopTheSpread.Org, who suggested GM work with Ventec.

StopTheSpread.org was founded by Kenneth Chenault, chairman and managing director at General Catalyst and the former chief executive and chairman of American Express, and Rachel Romer Carlson, the chief executive and co-founder of Guild Education.

  • GM and Ventec executives had their first conference call on Wednesday, March 18 to explore how GM may be able to help Ventec increase ventilator production.
  • The next day, a GM team flew to Seattle to meet with the Ventec team and roll up their sleeves to help.
  • On Friday, March 20, GM engaged its global supply base and within 72 hours, they had developed plans to source 100 percent of the necessary parts.
  • The UAW’s national and local leadership embraced the project and on Wednesday, March 25, crews began preparing the Kokomo site for production.
  • Mass production begins in mid-April. Production will quickly scale up to 10,000 critical care ventilators or more per month.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy